• Health Research Alliance, Inc
    $5,000 through May, 2018

    for participation in a learning community of funders interested in medical research.

    Multiple Sclerosis USA Awarded: May, 2017
  • Race to Erase MS
    $50,000 through May, 2017

    to support the Center without Walls Program.

    Multiple Sclerosis USA Awarded: May, 2016
  • Foundation for the National Institutes of Health
    $1,500 through May, 2017

    to fund MS research at the Translational Neuroradiology Unit of NINDs.

    Multiple Sclerosis USA Awarded: May, 2016
  • National Multiple Sclerosis Society, Southern California & Nevada Chapter
    $50,000 through April, 2017

    to support the International Progressive MS Alliance convening.

    Multiple Sclerosis Global Awarded: April, 2016
  • Winthrop University Hospital Association
    $440,000 through June, 2017

    to develop a minimally invasive DNA-based biomarker assay for the detection of cell loss in autoimmune diseases.

    Multiple Sclerosis USA Awarded: November, 2014
  • J. David Gladstone Institutes
    $495,000 through June, 2017

    to explore the potential of the coagulation cascade as a unique niche for biomarkers in progressive Multiple Sclerosis.

    Multiple Sclerosis USA Awarded: November, 2014
  • Salk Institute for Biological Studies
    $900,000 through December, 2017

    to develop in vitro models to study subtypes of MS using human cells.

    Multiple Sclerosis USA Awarded: November, 2014
  • Myelin Repair Foundation
    $1,350,000 through August, 2017

    to provide flexible funding for Myelin Repair Foundation-sponsored research and to build fundraising capacity.

    Multiple Sclerosis USA Awarded: August, 2014
  • University of California San Francisco
    $885,000 through May, 2017

    for a digital portal that manages, accesses, and displays multi-dimensional patient information in a tablet application that quantifies clinical outcomes and predicts disease trajectories for MS patients.

    Multiple Sclerosis USA Awarded: November, 2013
  • Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical
    $900,000 through December, 2017

    for research into the role of serum Vitamin A in halting disease progression in Relapsing-Remitting MS and its role as a factor in promoting remyelination.

    Multiple Sclerosis USA Awarded: November, 2013